Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5‐year study of patients with hepatitis B with lamivudine resistance
暂无分享,去创建一个
A. Takaki | Kazuhide Yamamoto | Y. Takeuchi | T. Yasunaka | F. Ikeda | Y. Miyake | Y. Iwasaki | K. Takaguchi | H. Kobashi | Yuki Moritou | S. Fujioka | J. Kubota | Nobuyuki Baba | K. Miyoshi | Junichi Kubota